Dna X (SONM) Enterprise Value (2019 - 2026)

Dna X (SONM) has 9 years of Enterprise Value data on file, last reported at -$1.2 million in Q1 2026.

• Quarterly Enterprise Value rose 75.71% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (up 75.71% YoY) and the FY2025 annual result came in at -$1.3 million, up 83.79% from the prior year.
• Enterprise Value grew to -$1.2 million in Q1 2026, from -$1.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$281000.0 in Q2 2023 to a low of -$15.5 million in Q3 2022.
• A 5-year average of -$6.1 million and a median of -$5.4 million in 2025 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2022 — Enterprise Value jumped 87.77% — and 2024, when it slumped 3316.37%.
• Tracing SONM's Enterprise Value over 5 years: stood at -$1.5 million in 2022, then sank by 539.17% to -$9.6 million in 2023, then advanced by 16.2% to -$8.0 million in 2024, then jumped by 83.79% to -$1.3 million in 2025, then grew by 8.29% to -$1.2 million in 2026.
• The last three Enterprise Value figures came in at -$1.2 million (Q1 2026), -$1.3 million (Q4 2025), and -$4.3 million (Q3 2025), per Business Quant data.